UK markets close in 5 hours 22 minutes

Ion Beam Applications SA (0GZK.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
16.98+0.38 (+2.29%)
As of 05:50PM BST. Market open.
Full screen
Previous close16.60
Open16.74
BidN/A x N/A
AskN/A x N/A
Day's range16.74 - 16.74
52-week range16.74 - 16.74
Volume29
Avg. volumeN/A
Market cap4.959M
Beta (5Y monthly)0.63
PE ratio (TTM)1.32
EPS (TTM)0.13
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    IBA, Fred Hutchinson Cancer Center and the University of Washington engage in a bench-to-bedside research program for FLASH Proton Therapy

    Louvain-la-Neuve, Belgium, August 2, 2022, IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, Fred Hutchinson Cancer Center and the University of Washington (UW), Seattle, announced a multi-year research collaboration today on ConformalFLASH®1 Proton Therapy. Under this collaboration, IBA will equip the proton therapy system and the proton gantry treatment room at the Fred Hutchinson Cancer Center with ConformalFLASH® research functionality, which wi

  • Globe Newswire

    IBA signs contract with Istituto Clinico Humanitas for a Proteus®ONE proton therapy solution in Italy

    Louvain-La-Neuve, Belgium, June 30, 2022 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a contract with Istituto Clinico Humanitas (Humanitas Research Hospital) for the installation of a Proteus®ONE1 compact proton therapy solution in Rozzano (Milan), Italy. IBA will start to recognize the revenue of this contract in 2022. The

  • Globe Newswire

    IBA signs Proteus®ONE contract with Baptist Health’s Lynn Cancer Institute for a new proton therapy center in South Florida, USA

    Louvain-La-Neuve, Belgium, 1 June, 2022 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces a contract with Eugene M. & Christine E. Lynn Cancer Institute of Boca Raton Regional Hospital, part of Baptist Health South Florida, for the installation of its Proteus®ONE1 compact proton therapy system. This project represents the second proton therapy